217 filings
Page 5 of 11
UPLOAD
4ctyk1qtf7ho7y0a
14 Oct 20
Letter from SEC
12:00am
UPLOAD
e69iz0
29 Sep 20
Letter from SEC
12:00am
8-K
bl9l4pay nvc
13 Aug 20
Novocure Announces Expansion of its Executive Leadership Team
8:45am
8-K
ap6e0ydjh
6 Aug 20
Termination of a Material Definitive Agreement
4:09pm
8-K
7qt2d3f6v
30 Jul 20
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
8:11am
8-K
ugtjq55 y8ufe6
15 Jul 20
Regulation FD Disclosure
10:38am
8-K
7g57ud7b3 g9
12 Jun 20
Departure of Directors or Certain Officers
4:10pm
8-K
x9s72j9etkd
13 May 20
China NMPA Approves OptuneĀ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
10:19am
8-K
rzt05y uko73hm0gd82
30 Apr 20
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
6:13am
DEFA14A
wl5mescrdtae2ejpw
27 Apr 20
Additional proxy soliciting materials
4:45pm
8-K
tcui2x pf
24 Apr 20
Departure of Directors or Certain Officers
5:19pm
8-K
es961hmtbqlv8cx hpsb
6 Mar 20
Departure of Directors or Certain Officers
4:19pm
S-8
f5c7wkoo6p262sj9q
3 Mar 20
Registration of securities for employees
4:05pm
8-K
5v3i6b
27 Feb 20
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
6:07am